DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,200
+150 (0.65%)
Nov 17, 2026, 9:35 AM KST

DongKook Pharmaceutical Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, DongKook Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩31,000. The average 1-year stock price forecast is 33.62% higher than the current stock price, while the lowest is ₩30,000 (+29.31%) and the highest is ₩32,000 (+37.93%).

Price Target: ₩31,000 (+33.62%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₩30,000₩31,000₩31,000₩32,000
Change+29.31%+33.62%+33.62%+37.93%

Analyst Ratings

The average analyst rating for DongKook Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Aug '26Sep '26Oct '26
Strong Buy111111
Buy000001
Hold000000
Sell000000
Strong Sell000000
Total111112

Financial Forecast

Revenue This Year
1.03T
from 926.88B
Increased by 11.60%
Revenue Next Year
1.17T
from 1.03T
Increased by 13.26%
EPS This Year
1.92K
from 1.48K
Increased by 30.14%
EPS Next Year
2.27K
from 1.92K
Increased by 18.18%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
594.19B661.65B730.99B812.17B926.88B1.03T
Revenue Growth
6.28%11.35%10.48%11.10%14.12%11.60%
Gross Profit
349.92B379.65B410.55B447.57B501.23B568.92B
Gross Margin
58.89%57.38%56.16%55.11%54.08%55.00%
Operating Income
63.22B73.54B66.87B79.86B96.47B108.20B
Net Income
50.35B52.90B47.18B61.22B66.02B87.00B
EPS
----1,475.001,919.50
EPS Growth
----7.82%30.14%
Forward PE
15.8211.6411.6611.019.8712.09
Dividend / Share
----200.00200.00
Free Cash Flow
-----54.00B
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.

Revenue Forecast

Revenue202620272028
High1.0T
Avg1.0T
Low1.0T

Revenue Growth

Revenue Growth202620272028
High
12.3%
Avg
11.6%
Low
10.9%

EPS Forecast

EPS202620272028
High1,982.00
Avg1,919.50
Low1,857.00

EPS Growth

EPS Growth202620272028
High
34.4%
Avg
30.1%
Low
25.9%